Header Logo

LINA MERJANEH

Concepts (65)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cystic Fibrosis
4
2023
257
1.820
 Why?
Hyperglycemia
2
2023
222
1.350
 Why?
Vomiting
1
2021
105
0.700
 Why?
Autoantibodies
1
2022
434
0.650
 Why?
Polycystic Ovary Syndrome
1
2019
58
0.610
 Why?
Disease Progression
3
2023
2044
0.570
 Why?
Diabetes Mellitus, Type 2
4
2024
1259
0.520
 Why?
Hypopituitarism
1
2015
17
0.490
 Why?
Shock
1
2015
90
0.460
 Why?
Diabetes Mellitus
1
2022
854
0.450
 Why?
Prediabetic State
1
2014
57
0.430
 Why?
Insulin-Secreting Cells
1
2014
149
0.410
 Why?
Gastroenteritis
1
2015
348
0.400
 Why?
Diabetes Mellitus, Type 1
3
2024
813
0.340
 Why?
Glucose Tolerance Test
2
2020
208
0.280
 Why?
Adolescent
8
2024
19266
0.260
 Why?
Young Adult
6
2024
9004
0.240
 Why?
Acute Disease
2
2020
1109
0.240
 Why?
Insulin
2
2022
1200
0.220
 Why?
Blood Glucose Self-Monitoring
1
2023
120
0.200
 Why?
Hypoglycemia
1
2022
191
0.180
 Why?
Diabetic Ketoacidosis
1
2022
160
0.170
 Why?
Menstruation Disturbances
1
2019
13
0.160
 Why?
Child
5
2024
24372
0.160
 Why?
Hyperandrogenism
1
2019
19
0.160
 Why?
Vascular Stiffness
1
2020
73
0.160
 Why?
Blood Glucose
1
2023
1135
0.160
 Why?
Glucose
1
2023
879
0.150
 Why?
Humans
11
2024
124297
0.150
 Why?
Monitoring, Physiologic
1
2020
356
0.150
 Why?
Cholesterol, LDL
1
2020
567
0.130
 Why?
Combined Modality Therapy
1
2019
1229
0.120
 Why?
Thyroid Hormones
1
2015
67
0.120
 Why?
Hydrocortisone
1
2015
217
0.120
 Why?
Cardiovascular Diseases
2
2024
1942
0.110
 Why?
Prevalence
1
2020
2445
0.110
 Why?
Male
5
2024
61050
0.110
 Why?
Diagnosis, Differential
1
2019
1881
0.110
 Why?
Glucose Intolerance
1
2014
78
0.110
 Why?
Statistics, Nonparametric
1
2014
427
0.110
 Why?
Hormone Replacement Therapy
1
2015
196
0.100
 Why?
Reference Values
1
2014
711
0.100
 Why?
Incidence
2
2024
3135
0.100
 Why?
Practice Guidelines as Topic
1
2019
1264
0.100
 Why?
Age Factors
2
2020
2808
0.100
 Why?
Time Factors
1
2022
6279
0.100
 Why?
Cross-Sectional Studies
2
2022
3416
0.090
 Why?
Adult
3
2023
29377
0.090
 Why?
Sex Factors
1
2014
1278
0.090
 Why?
Pediatrics
1
2019
1159
0.080
 Why?
Female
4
2024
66330
0.080
 Why?
Comorbidity
1
2014
1530
0.080
 Why?
Prognosis
1
2014
4609
0.060
 Why?
Risk Assessment
1
2014
3429
0.060
 Why?
Forced Expiratory Volume
1
2023
171
0.050
 Why?
Adrenal Cortex Hormones
1
2023
317
0.040
 Why?
Diabetic Angiopathies
1
2020
65
0.040
 Why?
Age of Onset
1
2020
586
0.040
 Why?
Insulin Resistance
1
2020
637
0.030
 Why?
Prospective Studies
1
2023
6123
0.020
 Why?
Anti-Bacterial Agents
1
2023
2427
0.020
 Why?
Cohort Studies
1
2020
4779
0.020
 Why?
Risk Factors
1
2024
10244
0.020
 Why?
United States
1
2020
10876
0.010
 Why?
Retrospective Studies
1
2023
16299
0.010
 Why?
MERJANEH's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (65)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_